FrancophonIA/ELRC3.0 huggingface dataset:
English: Each orodispersible tablet contains 10 mg olanzapine.
Croatian: Svaka raspadljiva tableta za usta sadrži 10 mg olanzapina.
English: EU/1/07/415/001 (14 tablets) EU/1/07/415/002 (28 tablets) EU/1/07/415/003 (35 tablets) EU/1/07/415/004 (56 tablets) EU/1/07/415/005 (70 tablets)
Croatian: EU/1/07/415/001 (14 tableta) EU/1/07/415/002 (28 tableta) EU/1/07/415/003 (35 tableta) EU/1/07/415/004 (56 tableta) EU/1/07/415/005 (70 tableta)
English: EU/1/07/415/022 (14 tablets) EU/1/07/415/023 (28 tablets) EU/1/07/415/024 (35 tablets) EU/1/07/415/025 (56 tablets) EU/1/07/415/026 (70 tablets)
Croatian: EU/1/07/415/022 (14 tableta) EU/1/07/415/023 (28 tableta) EU/1/07/415/024 (35 tableta) EU/1/07/415/025 (56 tableta) EU/1/07/415/026 (70 tableta)
English: BLISTER FOR ZALASTA 10 mg ORODISPERSIBLE TABLETS
Croatian: BLISTER ZA ZALASTA 10 mg RASPADLJIVE TABLETE ZA USTA
English: Zalasta 5 mg orodispersible tablets
Croatian: Zalasta 5 mg raspadljive tablete za usta
English: Zalasta 10 mg tablets: available in boxes of 7, 14, 28, 35, 56 and 70 tablets in blisters.
Croatian: Zalasta 10 mg tablete: dostupne su u kutijama od 7, 14, 28, 35, 56 i 70 tableta u blisteru.
English: Changes in total fasting cholesterol levels from borderline at baseline (≥ 5.17-< 6.2 mmol/l) to high (≥ 6.2 mmol/l) were very common.
Croatian: (≥ 5,17-< 6,2 mmol/l) do visokih vrijednosti (≥ 6,2 mmol/l) bile su vrlo česte.
English: EU/1/07/415/027 (14 tablets) EU/1/07/415/028 (28 tablets) EU/1/07/415/029 (35 tablets) EU/1/07/415/030 (56 tablets) EU/1/07/415/031 (70 tablets)
Croatian: EU/1/07/415/027 (14 tableta) EU/1/07/415/028 (28 tableta) EU/1/07/415/029 (35 tableta) EU/1/07/415/030 (56 tableta) EU/1/07/415/031 (70 tableta)
English: Zalasta 20 mg orodispersible tablets
Croatian: Zalasta 20 mg raspadljive tablete za usta
English: CARTON FOR ZALASTA 5 mgTABLETS
Croatian: KUTIJA ZA ZALASTA 5 mgTABLETE
English: Zalasta 20 mg tablets: available in boxes of 14, 28, 35, 56 and 70 tablets in blisters.
Croatian: Zalasta 20 mg tablete: dostupne su u kutijama od 14, 28, 35, 56 i 70 tableta u blisteru.
English: Zalasta 10 mg tablets are: round, slightly biconvex, slightly yellow tablets with possible individual yellow spots and an inscription 10.
Croatian: Zalasta tablete od 10 mg su: okrugle, blago bikonveksne, svijetlo žute tablete s mogućim pojedinačnim žutim mrljama i oznakom 10.
English: BLISTER FOR ZALASTA 15 mg ORODISPERSIBLE TABLETS
Croatian: BLISTER ZA ZALASTA 15 mg RASPADLJIVE TABLETE ZA USTA
English: Zalasta 7.5 mg orodispersible tablets
Croatian: Zalasta 7,5 mg raspadljive tablete za usta
English: BLISTER FOR ZALASTA 5 mg TABLETS
Croatian: BLISTER ZA ZALASTA 5 mg TABLETE
English: Zalasta 10 mg tablets Blister (OPA/Alu/PVC, Alu-foil): 7, 14, 28, 35, 56 or 70 tablets in a box.
Croatian: Zalasta 10 mg tablete Blister (OPA/Al/PVC, Al-folija): 7, 14, 28, 35, 56 ili 70 tableta u kutiji.
English: Zalasta 20 mg tablets Blister (OPA/Alu/PVC, Alu-foil): 14, 28, 35, 56 or 70 tablets in a box.
Croatian: Zalasta 20 mg tablete Blister (OPA/Al/PVC, Al-folija): 14, 28, 35, 56 ili 70 tableta u kutiji.
English: EU/1/07/415/047 (14 orodispersible tablets) EU/1/07/415/048 (28 orodispersible tablets) EU/1/07/415/049 (35 orodispersible tablets) EU/1/07/415/050 (56 orodispersible tablets) EU/1/07/415/051 (70 orodispersible tablets)
Croatian: EU/1/07/415/047 (14 raspadljivih tableta za usta) EU/1/07/415/048 (28 raspadljivih tableta za usta) EU/1/07/415/049 (35 raspadljivih tableta za usta) EU/1/07/415/050 (56 raspadljivih tableta za usta) EU/1/07/415/051 (70 raspadljivih tableta za usta)
English: EU/1/07/415/011 (14 tablets) EU/1/07/415/012 (28 tablets) EU/1/07/415/013 (35 tablets) EU/1/07/415/014 (56 tablets) EU/1/07/415/015 (70 tablets)
Croatian: EU/1/07/415/011 (14 tableta) EU/1/07/415/012 (28 tableta) EU/1/07/415/013 (35 tableta) EU/1/07/415/014 (56 tableta) EU/1/07/415/015 (70 tableta)
English: Zalasta 10 mg orodispersible tablets
Croatian: Zalasta 10 mg raspadljive tablete za usta
English: EU/1/07/415/052 (14 orodispersible tablets) EU/1/07/415/053 (28 orodispersible tablets) EU/1/07/415/054 (35 orodispersible tablets) EU/1/07/415/055 (56 orodispersible tablets) EU/1/07/415/056 (70 orodispersible tablets)
Croatian: EU/1/07/415/052 (14 raspadljivih tableta za usta) EU/1/07/415/053 (28 raspadljivih tableta za usta) EU/1/07/415/054 (35 raspadljivih tableta za usta) EU/1/07/415/055 (56 raspadljivih tableta za usta) EU/1/07/415/056 (70 raspadljivih tableta za usta)
English: BLISTER FOR ZALASTA 5 mg ORODISPERSIBLE TABLETS
Croatian: BLISTER ZA ZALASTA 5 mg RASPADLJIVE TABLETE ZA USTA
English: EU/1/07/415/037 (14 orodispersible tablets) EU/1/07/415/038 (28 orodispersible tablets) EU/1/07/415/039 (35 orodispersible tablets) EU/1/07/415/040 (56 orodispersible tablets) EU/1/07/415/041 (70 orodispersible tablets)
Croatian: EU/1/07/415/037 (14 raspadljivih tableta za usta) EU/1/07/415/038 (28 raspadljivih tableta za usta) EU/1/07/415/039 (35 raspadljivih tableta za usta) EU/1/07/415/040 (56 raspadljivih tableta za usta) EU/1/07/415/041 (70 raspadljivih tableta za usta)
English: Równoległa 5
Croatian: Sp. z o.o. ul. Równoległa 5
English: EU/1/07/415/042 (14 orodispersible tablets) EU/1/07/415/043 (28 orodispersible tablets) EU/1/07/415/044 (35 orodispersible tablets) EU/1/07/415/045 (56 orodispersible tablets) EU/1/07/415/046 (70 orodispersible tablets)
Croatian: EU/1/07/415/042 (14 raspadljivih tableta za usta) EU/1/07/415/043 (28 raspadljivih tableta za usta) EU/1/07/415/044 (35 raspadljivih tableta za usta) EU/1/07/415/045 (56 raspadljivih tableta za usta) EU/1/07/415/046 (70 raspadljivih tableta za usta)
English: EU/1/07/415/032 (14 orodispersible tablets) EU/1/07/415/033 (28 orodispersible tablets) EU/1/07/415/034 (35 orodispersible tablets) EU/1/07/415/035 (56 orodispersible tablets) EU/1/07/415/036 (70 orodispersible tablets)
Croatian: EU/1/07/415/032 (14 raspadljivih tableta za usta) EU/1/07/415/033 (28 raspadljivih tableta za usta) EU/1/07/415/034 (35 raspadljivih tableta za usta) EU/1/07/415/035 (56 raspadljivih tableta za usta) EU/1/07/415/036 (70 raspadljivih tableta za usta)
English: Tablets are round, slightly biconvex, slightly yellow tablets with possible individual yellow spots and an inscription “15”.
Croatian: Tablete su okrugle, blago bikonveksne, svijetlo žute s mogućim pojedinačnim žutim mrljama i utisnutom oznakom “15”.
English: Tablets are round, slightly biconvex, slightly yellow tablets with possible individual yellow spots and an inscription “10”.
Croatian: Tablete su okrugle, blago bikonveksne, svijetlo žute s mogućim pojedinačnim žutim mrljama i utisnutom oznakom “10”.
English: - If you get any side effects talk to your doctor or pharmacist.
Croatian: Ako imate bilo koji od gornjih simptoma, odmah se obratite svom liječniku ili bolnici.
English: Tablets are round, slightly biconvex, slightly yellow tablets with possible individual yellow spots and an inscription “5”.
Croatian: Tablete su okrugle, blago bikonveksne, svijetlo žute s mogućim pojedinačnim žutim mrljama i utisnutom oznakom "5".
English: Zalasta 5 mg tablets are: round, slightly biconvex, slightly yellow tablets with possible individual yellow spots and an inscription 5.
Croatian: Zalasta tablete od 5 mg su: okrugle, blago bikonveksne, svijetlo žute tablete s mogućim pojedinačnim žutim mrljama i oznakom 5.
English: Zalasta 15 mg tablets are: round, slightly biconvex, slightly yellow tablets with possible individual yellow spots and an inscription 15.
Croatian: Zalasta tablete od 15 mg su: okrugle, blago bikonveksne, svijetlo žute tablete s mogućim pojedinačnim žutim mrljama i oznakom 15.
English: Zalasta 15 mg orodispersible tablets
Croatian: Zalasta 15 mg raspadljive tablete za usta
English: us
Croatian: Ako
English: Elevated glucose levels
Croatian: Visoka razina mokraćne kiseline
English: Zalasta 7.5 mg tablets: available in boxes of 14, 28, 35, 56 and 70 tablets in blisters.
Croatian: Zalasta 7,5 mg tablete: dostupne su u kutijama od 14, 28, 35, 56 i 70 tableta u blisteru.
English: Zalasta 7.5 mg tablets Blister (OPA/Alu/PVC, Alu-foil): 14, 28, 35, 56 or 70 tablets in a box.
Croatian: Zalasta 7,5 mg tablete Blister (OPA/Al/PVC, Al-folija): 14, 28, 35, 56 ili 70 tableta u kutiji.
English: Zalasta 7.5 mg orodispersible tablets Olanzapine
Croatian: Zalasta 7,5 mg raspadljive tablete za usta olanzapin
English: Zalasta 2.5 mg tablets: available in boxes of 14, 28, 35, 56 and 70 tablets in blister.
Croatian: Zalasta 2,5 mg tablete: dostupne su u kutijama od 14, 28, 35, 56 i 70 tableta u blisteru.
English: Zalasta 20 mg orodispersible tablets Olanzapine
Croatian: Zalasta 20 mg raspadljive tablete za usta olanzapin
English: LABELLING AND PACKAGE LEAFLET
Croatian: Kako Zalasta izgleda i sadržaj pakiranja
English: Zalasta 5 mg tablets Blister (OPA/Alu/PVC, Alu-foil): 14, 28, 35, 56 or 70 tablets in a box.
Croatian: Zalasta 5 mg tablete Blister (OPA/Al/PVC, Al-folija): 14, 28, 35, 56 ili 70 tableta u kutiji.
English: Zalasta 5 mg tablets: available in boxes of 14, 28, 35, 56 and 70 tablets in blisters.
Croatian: Zalasta 5 mg tablete: dostupne su u kutijama od 14, 28, 35, 56 i 70 tableta u blisteru.
English: Zalasta 15 mg tablets Blister (OPA/Alu/PVC, Alu-foil): 14, 28, 35, 56 or 70 tablets in a box.
Croatian: Zalasta 15 mg tablete Blister (OPA/Al/PVC, Al-folija): 14, 28, 35, 56 ili 70 tableta u kutiji.
English: Tardive Dyskinesia
Croatian: Dizartrija Mucanje
English: Zalasta 15 mg tablets: available in boxes of 14, 28, 35, 56 and 70 tablets in blisters.
Croatian: Zalasta 15 mg tablete: dostupne su u kutijama od 14, 28, 35, 56 i 70 tableta u blisteru.
English: Epistaxis
Croatian: Pankreatitis
English: Zalasta 10 mg orodispersible tablets Olanzapine
Croatian: Zalasta 10 mg raspadljive tablete za usta olanzapin
English: Zalasta 15 mg tablets Each tablet contains 242.7 mg lactose.
Croatian: Svaka tableta sadrži 242,7 mg laktoze.
English: Zalasta 2.5 mg tablets Blister (OPA/Alu/PVC, Alu-foil): 14, 28, 35, 56 or 70 tablets in a box.
Croatian: Zalasta 2,5 mg tablete Blister (OPA/Al/PVC, Al-folija): 14, 28, 35, 56 ili 70 tableta u kutiji.
English: Abdominal distension 9 Pancreatitis
Croatian: Distenzija abdomena
English: Zalasta 15 mg orodispersible tablets Tablets are round, slightly biconvex, yellow marbled tablets with possible individual spots.
Croatian: Tablete su okrugle, blago bikonveksne, žute, mramorirane tablete s mogućim pojedinačnim mrljama.
English: CARTON FOR ZALASTA 20 mg ORODISPERSIBLE TABLETS
Croatian: KUTIJA ZA ZALASTA 20 mg RASPADLJIVE TABLETE ZA USTA
English: Zalasta 5 mg orodispersible tablets Olanzapine
Croatian: Zalasta 5 mg raspadljive tablete za usta olanzapin
English: Zalasta 5 mg orodispersible tablets Zalasta 7.5 mg orodispersible tablets Zalasta 10 mg orodispersible tablets Zalasta 15 mg orodispersible tablets Zalasta 20 mg orodispersible tablets
Croatian: Zalasta 5 mg raspadljive tablete za usta Zalasta 7,5 mg raspadljive tablete za usta Zalasta 10 mg raspadljive tablete za usta Zalasta 15 mg raspadljive tablete za usta Zalasta 20 mg raspadljive tablete za usta
English: Zalasta 5 mg orodispersible tablets Zalasta 7.5 mg orodispersible tablets Zalasta 10 mg orodispersible tablets Zalasta 15 mg orodispersible tablets Zalasta 20 mg orodispersible tablets Olanzapine
Croatian: Zalasta 5 mg raspadljive tablete za usta Zalasta 7,5 mg raspadljive tablete za usta Zalasta 10 mg raspadljive tablete za usta Zalasta 15 mg raspadljive tablete za usta Zalasta 20 mg raspadljive tablete za usta olanzapin
English: Renal and/or hepatic impairment
Croatian: Oštećenje funkcije bubrega i/ili jetre
English: How to store Zalasta
Croatian: Kako čuvati Zalastu
English: Further information on Jivi can be found on the Agency's website: ema.europa.eu/medicines/human/EPAR/Jivi.
Croatian: Više informacija o lijeku Jivi nalazi se na internetskim stranicama Agencije: ema.europa.eu/medicines/human/EPAR/Jivi.
English: Jivi is given by injection into a vein.
Croatian: Jivi se daje injekcijom u venu.
English: What measures are being taken to ensure the safe and effective use of Jivi?
Croatian: Koje se mjere poduzimaju kako bi se osigurala sigurna i učinkovita primjena lijeka Jivi?
English: The most common side effect with Jivi (which may affect more than 1 in 10 people) is headache.
Croatian: Najčešća nuspojava lijeka Jivi (koja se može javiti u više od 1 na 10 osoba) jest glavobolja.
English: Jivi can be used in adults and children from 12 years of age who have been treated previously.
Croatian: Jivi se može koristiti u odraslih i djece od 12 godina i starijih koji su prethodno liječeni.
English: Why is Jivi authorised in the EU?
Croatian: Zašto je Jivi odobren u EU-u?
English: In such cases, a specialised haemophilia centre should be contacted.
Croatian: U tim slučajevima potrebno je kontaktirati specijalizirane centre za liječenje hemofilije.
English: What is Jivi and what is it used for?
Croatian: Što je Jivi i za što se primjenjuje?
English: Jivi was rated good or excellent at stopping bleeding in all surgeries.
Croatian: Jivi je ocijenjen dobrim ili izvrsnim pri zaustavljanju krvarenja kod svih operacija.
English: Since this could potentially cause problems especially in children below 12 years of age, Jivi is only approved for use in adults and children from 12 years of age.
Croatian: Budući da to može potencijalno uzrokovati probleme, osobito u djece mlađe od 12 godina, lijek Jivi odobrava se za primjenu samo u odraslih osoba i djece u dobi od 12 ili više godina.
English: Hypersensitivity (allergic) reactions are common with Jivi (affecting up to 1 in 10 people) and may include swelling, burning and stinging at the injection site, chills, flushing, tingling, itchy rash, headache, hives, low blood pressure, lethargy, nausea and vomiting, restlessness, a rapid heartbeat, tightness of the chest and wheezing.
Croatian: Reakcije preosjetljivosti (alergijske reakcije) česte su pri primjeni lijeka Jivi (javljaju se u do 1 na 10 osoba), a uključuju oticanje, žarenje i peckanje na mjestu injekcije, zimicu, navalu crvenila, peckanje, osip praćen svrbežom, glavobolju, koprivnjaču, nizak krvni tlak, letargiju, mučninu i povraćanje, nemir, brzo kucanje srca, stezanje u prsima i piskanje pri disanju.
English: Jivi (damoctocog alfa pegol)
Croatian: Jivi (damoktokog alfa pegol)
English: Other information about Jivi
Croatian: Ostale informacije o lijeku Jivi
English: Side effects reported with Jivi are carefully evaluated and any necessary action taken to protect patients.
Croatian: Nuspojave prijavljene za lijek Jivi pažljivo se procjenjuju i poduzimaju se potrebne mjere za zaštitu bolesnika.
English: As for all medicines, data on the use of Jivi are continuously monitored.
Croatian: Kao i za sve lijekove, podatci o primjeni lijeka Jivi kontinuirano se prate.
English: The European Medicines Agency decided that Jivi's benefits are greater than its risks and it can be authorised for use in the EU.
Croatian: Europska agencija za lijekove zaključila je da koristi od lijeka Jivi nadmašuju s njim povezane rizike te da lijek može biti odobren za primjenu u Europskoj uniji.
English: Part of the active substance is a substance called polyethylene glycol, ‘PEG', which is included to help the medicine remain in the body for longer and thereby prolong its action.
Croatian: Dio djelatne tvari je tvar naziva „polietilenglikol” (PEG) koja je dodana kako bi lijek duže ostao u tijelu i stoga duže djelovao.
English: What are the risks associated with Jivi?
Croatian: Koji su rizici povezani s lijekom Jivi?
English: Jivi has been shown to be effective at reducing the number of bleeding episodes in patients with severe haemophilia and stopping bleeding when it occurs.
Croatian: Jivi se pokazao djelotvornim u smanjenju broja epizoda krvarenja u bolesnika s teškom hemofilijom i zaustavljanju krvarenja kad do njega dođe.
English: Recommendations and precautions to be followed by healthcare professionals and patients for the safe and effective use of Jivi have also been included in the summary of product characteristics and the package leaflet.
Croatian: Preporuke i mjere opreza kojih se zdravstveni radnici i bolesnici trebaju pridržavati u cilju sigurne i učinkovite primjene lijeka Jivi također se nalaze u sažetku opisa svojstava i u uputi o lijeku.
English: The company that markets Jivi will conduct a study to investigate the potential effects of PEG accumulation in the choroid plexus of the brain and other organs.
Croatian: Tvrtka koja stavlja u promet lijek Jivi provest će ispitivanje u svrhu istraživanja potencijalnih učinaka od nakupljanja PEG-a u koroidnom pleksusu mozga i drugim organima.
English: Patients or their carers may be able to inject Jivi themselves at home once they have been trained appropriately.
Croatian: Nakon odgovarajuće obuke, bolesnici ili njihovi njegovatelji mogu samostalno ubrizgavati lijek Jivi kod kuće.
English: An overview of Jivi and why it is authorised in the EU
Croatian: Pregled informacija o lijeku Jivi i zašto je odobren u EU-u
English: Jivi can only be obtained with a prescription and treatment should be under the supervision of a doctor who has experience in the treatment of haemophilia.
Croatian: Lijek Jivi izdaje se samo na liječnički recept, a liječenje se mora provoditi pod nadzorom liječnika s iskustvom u liječenju hemofilije.
English: The dose and frequency of treatment depend on whether it is used to treat or prevent bleeding, as well as on the severity of the haemophilia, the extent and location of the bleeding and the patient's condition and weight.
Croatian: Doza i učestalost liječenja ovise o tome primjenjuje li se lijek za liječenje ili sprječavanje krvarenja, kao i o stupnju hemofilije, jačini i mjestu krvarenja te općem stanju i tjelesnoj težini bolesnika.
English: Following treatment with factor VIII products, including Jivi, some patients may develop inhibitors (antibodies) against factor VIII, preventing the medicine from working effectively and resulting in a loss of bleeding control.
Croatian: Nakon liječenja lijekovima koji sadrže faktor VIII, uključujući Jivi, u nekih bolesnika mogu se razviti inhibitori (protutijela) faktora VIII koji onemogućuju djelovanje lijeka i dovode do gubitka kontrole nad krvarenjem.
English: The active substance in Jivi, damoctocog alfa pegol, works in the same way as the body's factor VIII.
Croatian: Djelatna tvar lijeka Jivi, damoktokog alfa pegol, djeluje na isti način kao i ljudski faktor VIII.
English: For more information about using Jivi, see the package leaflet or contact your doctor or pharmacist.
Croatian: Više informacija o primjeni lijeka Jivi pročitajte u uputi o lijeku, odnosno obratite se liječniku ili ljekarniku.
English: However, laboratory studies show that PEG, which is part of the active substance in Jivi, may accumulate in the body, including in a structure in the brain called the choroid plexus, following long-term treatment.
Croatian: Međutim, laboratorijska ispitivanja pokazuju da se PEG, koji je dio djelatne tvari lijeka Jivi, nakon dugotrajne terapije može akumulirati u organizmu, uključujući u dijelu mozga naziva koroidni pleksus.
English: Jivi must not be used in patients with allergy to mouse or hamster proteins.
Croatian: Jivi se ne smije davati bolesnicima s alergijskim reakcijama na bjelančevine miševa ili hrčaka.
English: In a second part of the study, 17 patients received Jivi to control bleeding during 20 major surgeries.
Croatian: U drugom dijelu ispitivanja, 17 bolesnika primilo je lijek Jivi za kontrolu krvarenja tijekom 20 kompleksnijih operacija.
English: In a second study in 61 children aged below 12 years, Jivi given as preventive treatment reduced the number of bleeding episodes to around 3 episodes a year.
Croatian: U drugom ispitivanju na 61 djetetu mlađem od 12 godina, Jivi je primijenjen kao preventivno liječenje te je smanjio broj epizoda krvarenja na otprilike 3 godišnje.
English: How does Jivi work?
Croatian: Kako djeluje Jivi?
English: The 20 patients who were given Jivi for treating bleeding when it occurred had around 23 bleeding episodes a year.
Croatian: Svih 20 bolesnika koji su primili Jivi za liječenje samog krvarenja iskusili su oko 23 epizode krvarenja godišnje.
English: Jivi contains the active substance damoctocog alfa pegol.
Croatian: Jivi sadrži djelatnu tvar damoktokog alfa pegol.
English: Jivi is a medicine used to treat and prevent bleeding in patients with haemophilia A, an inherited bleeding disorder caused by lack of a clotting protein called factor VIII.
Croatian: Jivi je lijek koji se primjenjuje za liječenje i sprječavanje krvarenja u bolesnika s hemofilijom A, nasljednim poremećajem krvarenja koji je uzrokovan manjkom bjelančevine za zgrušavanje naziva faktor VIII.
English: In a study of 134 patients from 12 years of age, 114 patients given Jivi as a preventive treatment had around 2 bleeding episodes per year.
Croatian: U ispitivanju na 134 bolesnika od 12 godina i starijih, njih 114 primilo je lijek Jivi kao preventivno liječenje te je iskusilo oko 2 epizode krvarenja godišnje.
English: Patients with haemophilia A lack factor VIII, a protein needed for blood to clot and, as a result, they bleed readily.
Croatian: Bolesnicima s hemofilijom A nedostaje faktor VIII, bjelančevina potrebna za zgrušavanje krvi, pa stoga lako krvare.
English: Studies show that Jivi is effective at preventing and treating bleeding episodes in patients with haemophilia A and its safety is comparable to that of other factor VIII products.
Croatian: Ispitivanja pokazuju da je lijek Jivi djelotvoran u sprječavanju i liječenju epizoda krvarenja u bolesnika s hemofilijom A te da je njegova sigurnost usporediva sa sigurnošću drugih lijekova koji sadrže faktor VIII.
English: What benefits of Jivi have been shown in studies?
Croatian: Koje su koristi od lijeka Jivi utvrđene u ispitivanjima?
English: How is Jivi used?
Croatian: Kako se Jivi primjenjuje?
English: Annex I List of the names, pharmaceutical form, strength of the medicinal product, route of administration, Marketing Authorisation Holders in the Member States
Croatian: Popis naziva, farmaceutskog oblika, jačine lijeka, puta primjene, nositelja odobrenja u državama članicama
English: AstraZeneca Kft. H-1113 Budapest Bocskai út 134-146 Hungary
Croatian: H-1113 Budapest Bocskai út 134-146 Hungary
English: Radnička cesta 80 10 000 Zagreb Croatia
Croatian: AstraZeneca d.o.o. Radnička cesta 80 10 000 Zagreb Croatia
English: AstraZeneca A/S Arne Jacobsens Allé 13 2300 Köbenhavn S. Denmark
Croatian: AstraZeneca A/S Arne Jacobsens Allé 13 2300 Köbenhavn S.
English: Luxembourg NV AstraZeneca SA Rue Egide van Ophemstraat B-1180 Brussel
Croatian: Luksemburg NV AstraZeneca SA Rue Egide van Ophemstraat B-1180 Brussel
English: Belgium NV AstraZeneca SA Rue Egide van Ophemstraat 110, B-1180 Brussel Belgium
Croatian: NV AstraZeneca SA Rue Egide van Ophemstraat 110, B-1180 Brussel Belgium
English: Gartunavagen, S-151 85 Sodertalje, Sweden
Croatian: Astra Zeneca AB Gartunavagen, S-151 85 Sodertalje, Sweden
English: AstraZeneca UK Ltd. 600 Capability Green Luton LU1 3LU United Kingdom
Croatian: 600 Capability Green Luton LU1 3LU United Kingdom
English: Theotokopoulou & Astronafton str 151 25 Maroussi
Croatian: Theotokopoulou & Astronafton str
English: Czech Republic AstraZeneca UK Limited 2 Kingdom Street
Croatian: AstraZeneca UK Limited 2 Kingdom Street London W2 6BD United Kingdom
English: Netherlands AstraZeneca BV Louis Pasteurlaan 5
Croatian: AstraZeneca BV Louis Pasteurlaan 5 2719 EE Zoetermeer The Netherlands
English: SIMESA S.p.A Palazzo Galileo Via F. Sforza 20080 Basiglio (MI) Italy
Croatian: SIMESA S.p.A Palazzo Galileo Via F.
English: AstraZeneca S.p.A Palazzo Volta Via F. Sforza 20080 Basiglio (MI) Italy
Croatian: AstraZeneca S.p.A Palazzo Volta Via F.
English: C/Serrano Galvache 56
Croatian: C/Serrano Galvache 56 Edificio Roble 28033 Madrid Spain
English: AstraZeneca d.o.o.
Croatian: AstraZeneca Kft.
English: Strimvelis is given by a drip (infusion) into a vein (intravenously).
Croatian: NAVOĐENJE DJELATNE(IH) TVARI
English: It must never be given to anyone else.
Croatian: Nikada se ne smije dati nekome drugome.
English: This will take about 20 minutes
Croatian: To će potrajati približno 20 minuta.
English: Time period (Years)
Croatian: Vremensko razdoblje (godine)
English: You may need other treatment
Croatian: Možda će biti potrebno drugo liječenje